New York 2023-2024 Regular Session

New York Assembly Bill A01962

Introduced
1/23/23  
Refer
1/23/23  

Caption

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

Companion Bills

NY S02393

Same As Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

Previously Filed As

NY S02393

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY S02128

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY A07142

Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.

NY SB1019

Health Benefit Plans - Prescription Drugs - Rebates and Calculation of Cost Sharing Requirements

NY HB1270

Health Benefit Plans - Prescription Drugs - Rebates and Calculation of Cost Sharing Requirements

NY HB509

Apply prescription drug rebates to cost-sharing requirements

NY A08136

Authorizes insurance policies which provide coverage for prescription drugs where cost-sharing obligations are determined by category of prescription drugs to offer a program to insureds that utilizes rebates or discounts to lower an insured's cost-sharing for prescription drugs if the insured's cost-sharing under such program would be more favorable than the cost-sharing that would otherwise be applicable to the prescription drug.

NY S07900

Authorizes insurance policies which provide coverage for prescription drugs where cost-sharing obligations are determined by category of prescription drugs to offer a program to insureds that utilizes rebates or discounts to lower an insured's cost-sharing for prescription drugs if the insured's cost-sharing under such program would be more favorable than the cost-sharing that would otherwise be applicable to the prescription drug.

NY SB2031

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

NY SB2223

Health insurance carriers; require to cap patient cost for prescriptions for insulin drugs.

Similar Bills

No similar bills found.